Journal article icon

Journal article

Treatment of intestinal Behcet's syndrome with chimeric tumour necrosis factor alpha antibody.

Abstract:

Few patients with Behçet's syndrome have gastrointestinal ulceration. Such patients are difficult to treat and have a higher mortality. Faced with refractory symptoms in two patients with intestinal Behçet's, we used the tumour necrosis factor alpha (TNF-alpha) monoclonal antibody infliximab to induce remission. Both women (one aged 27 years, the other 30 years) presented with orogenital ulceration, pustular rash, abdominal pain, bloody diarrhoea due to colonic ulceration, weight loss, and sy...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1136/gut.49.5.725

Authors


Travis, SP More by this author
Czajkowski, M More by this author
McGovern, DP More by this author
Watson, RG More by this author
Journal:
Gut
Volume:
49
Issue:
5
Pages:
725-728
Publication date:
2001-11-05
DOI:
EISSN:
1468-3288
ISSN:
0017-5749
URN:
uuid:b84acb86-33e6-42fb-86aa-fec30d98a4fc
Source identifiers:
323599
Local pid:
pubs:323599

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP